Cormedix Inc (CRMD) |
|
8.96 -0.19 (-2.08%)
|
11-29 21:00 |
|
Open: |
9.28 |
Pre. Close: |
9.15 |
|
High:
|
9.42 |
Low:
|
8.57 |
|
Volume:
|
536,497 |
Market Cap:
|
288M |
|
|
|
|
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. It primarily focuses on the development of its lead product candidate, Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, critical/intensive care, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was founded in 2006 and is based in Berkeley Heights, New Jersey. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
9.428 - 9.475 |
9.475 - 9.506 |
|
Low:
|
8.464 - 8.523 |
8.523 - 8.561 |
|
Close:
|
8.872 - 8.965 |
8.965 - 9.024 |
|
Technical analysis |
as of: 2020-11-29 9:20:15 AM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 11.00  One year: 12.85 |
| Support: |
Support1: 6.62 Support2: 4.89 |
| Resistance: |
Resistance1: 9.42 Resistance2: 11.00 |
| Pivot: |
6.61 |
| Moving Average: |
MA(5): 8.13 MA(20): 6.27
MA(100): 5.38 MA(250): 5.38 |
| MACD: |
MACD(12,26): 0.76 Signal(9): 0.41 |
| Stochastic oscillator: |
%K(14,3): 94.86 %D(3): 94.64 |
| RSI: |
RSI(14): 84.62 |
| 52-week: |
High: 9.42 Low: 2.16 Change(%): 43.1 |
| Average Vol(K): |
3-Month: 41533 10-Days: 49939 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.CRMD has closed below upper band by 2.0%. Bollinger Bands are 239.5% wider than normal. The large width of the bands suggest high volatility as compared to CRMD's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Sat, 28 Nov 2020
Is CorMedix Inc. (NYSE:CRMD) Potentially Life-Changing Stock? - Marketing Sentinel
Wed, 25 Nov 2020
Should You Buy CorMedix Inc. (CRMD) Stock? - InvestorsObserver
Sat, 21 Nov 2020
How is the CorMedix Inc. (NYSE:CRMD) performance outlook for the coming months? - Marketing Sentinel
Wed, 18 Nov 2020
CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting for New Drug Application for Defencath is Not Needed - Yahoo Finance
Fri, 13 Nov 2020
CorMedix: Patent Coverage Is A Problem - Seeking Alpha
Mon, 09 Nov 2020
Should You Buy CorMedix Inc. (CRMD) Stock on Monday? - InvestorsObserver
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
31 |
| Shares Float (M) |
29 |
|
% Held by Insiders
|
2.12 |
|
% Held by Institutions
|
24.72 |
|
Shares Short (K)
|
3,570 |
|
Shares Short P. Month (K)
|
3,640 |
Stock Financials |
|
EPS
|
-1.850 |
|
EPS Est This Year
|
-0.530 |
|
EPS Est Next Year
|
-0.280 |
|
Book Value (p.s.)
|
0.710 |
|
Profit Margin
|
|
|
Operating Margin
|
-14347.16 |
|
Return on Assets (ttm)
|
-60.5 |
|
Return on Equity (ttm)
|
-113.8 |
|
Qtrly Rev. Growth
|
-53.4 |
|
Gross Profit (p.s.)
|
-0.003 |
|
Sales Per Share
|
0.006 |
|
EBITDA (p.s.)
|
-0.801 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-17 |
|
Levered Free Cash Flow (M)
|
-13 |
Stock Valuations |
|
PE Ratio
|
-4.84 |
|
PEG Ratio
|
|
|
Price to Book value
|
12.62 |
|
Price to Sales
|
1601.23 |
|
Price to Cash Flow
|
-16.89 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
